Ignite Creation Date:
2025-12-24 @ 5:41 PM
Ignite Modification Date:
2025-12-28 @ 2:53 AM
Study NCT ID:
NCT05797168
Status:
RECRUITING
Last Update Posted:
2025-12-17
First Post:
2023-02-21
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-05
Start Date Type:
ACTUAL
Primary Completion Date:
2028-01-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-01-06
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-21
First Submit QC Date:
None
Study First Post Date:
2023-04-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-16
Last Update Post Date:
2025-12-17
Last Update Post Date Type:
ESTIMATED